Pentoxifylline - Osteoradionecrosis of the jaw
You are here : Home > Formulary Search > Pentoxifylline - Osteoradionecrosis of the jaw
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Red
Formulations :
- Modified release tablets
Formulary Status :
Restrictions / Comments :
Important
Restricted to Oral Surgeons only - with Vitamin E to start 1 week before extraction and for 3 months after (until good healing is observed)
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Pentoxifylline
Indication :
Osteoradionecrosis of the jaw
Group Name :
Keywords :
osteonecrosis of the jaw, ORN, ONJ
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Pentoxifylline is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Osteoradionecrosis of the jaw.
Committee Recommendations (1)
This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.
See “Formulary Status” to identify where this drug has been agreed for use.